Neil Dugdale

General Manager UK & Ireland • GenSight Biologics

Neil started working in the Pharmaceutical industry in 1994 as a Pharmaceutical Sales representative for Merck Pharmaceuticals, now Merck Serono, launched and ran his own consultancy business for a number of years before in 2013 rejoining Merck Serono as Director of Oncology. In 2015 he joined Sobi (Swedish Orphan Biovitrum) as GM for the UK and RoI and in 2018 he became VP & GM, UK-RoI;Nordics-Baltics. He left Sobi at the end of 2020 joining GenSight Biologics as Country Manager, UK/Ireland to lead the launch of a gene therapy. 
Neil is also a founding director of the not-for-profit organisation, Rare Disease Nurse Network and a mentor at START Codon in Cambridge, England. 
Neil holds a BSc (Hons) degree from the University of Liverpool, a diploma from the Chartered Institute of Marketing and recently completed studies in Digital Transformation at the University of Cambridge. He lives in St Albans, near London, England. 

‘I passionately believe that everyone in the healthcare sector can make an incredible positive difference to patient’s lives by helping healthcare professionals in many different ways so that they are able treat their patients in the best way possible. I believe it is our duty to help patient organisations so that they can continue their amazing work that gives so much help and support to patient’s and their families and friends’

Also speaking

Allison Blair

Head of Laboratory • NHS Blood and Transplant

Mark Trusheim

Strategic Director, NEWDIGS and Visiting Scientist, • Massachusetts Institute of Technology (MIT)

David Wolton

Engineering Technology Lead • Takeda

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.